Maryland Capital Management Invitae Corp Transaction History

Maryland Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $110,793 - $216,085	-7,537 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $25,355 - $35,044	1,043 Added 16.06%	7,537 $214,000
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $5,270 - $8,160	-202 Reduced 3.02%	6,494 $219,000
Q1 2021 May 11, 2021	BUY	$33.06 - $56.93 $221,369 - $381,203	6,696 New	6,696 $256,000

2.08M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

Stay updated on Maryland Capital Management with notifications on news.